[ad_1]
SANTA BARBARA, Calif., July 12, 2021 (GLOBE NEWSWIRE) – Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetic company focused solely on plastic surgeons announced today that Andy Schmidt has been appointed Chief Financial Officer (CFO) with immediate effect. As a key member of Sientra’s Executive Leadership Team, Mr. Schmidt will lead the company’s financial operations.
“We are very excited to have a strong leader like Andy on the Sientra team. His experience with growth-oriented public companies will be invaluable as we work to expand our market share and advance the art of plastic surgery, ”said Ron Menezes, President and Chief Executive Officer of Sientra. “We are fortunate to have a strong finance team and now have a smooth transition plan that will allow us to take the next step in advancing our breast products and financial performance.”
Mr. Schmidt brings more than 20 years of financial leadership experience to Sientra and has successfully led the finance, M&A and capital markets strategies of numerous publicly traded companies. Most recently, he was CFO of Guardion Health Sciences, a Nasdaq-listed company focused on clinical nutrition, diagnostics and medical devices. During his tenure at Guardion, Mr. Schmidt was part of a team that raised $ 35 million and also restored the company to Nasdaq listing. He was previously the CFO of Iteris, Inc., a publicly traded global technology company. With a focus on internal and external strategic development and implementation, Mr. Schmidt accelerated growth and achieved a record performance for the share. He was previously the CFO of publicly traded Smith Micro Software, Inc. and Genius Products, Inc. He previously held senior finance positions at Peregrine Systems and Mad Catz Interactive.
“I’m very excited to join one of the fastest growing medical aesthetics companies in the United States,” said Schmidt. “I look forward to working with the team to accelerate Sientra’s growth and support its goal of becoming the top two breast implant companies in two years.”
Mr. Schmidt earned a Masters of Science in Accountancy from San Diego State University and a Bachelor of Business Administration in Finance from the University of Texas, Austin, TX. His honors include two academic awards / scholarships and a full sports scholarship. In swimming, he achieved All-America status, won the US National Championship and served as a member of the US National Swimming Team.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetic company focused solely on plastic surgeons. The company’s mission is to offer proprietary innovations and unparalleled partnerships that radically advance the way plastic surgeons think, work and care. Sientra has developed a broad product portfolio with technologically differentiated properties, which is supported by independent laboratory tests and convincing results of clinical studies. The company’s Breast Products segment includes the Sientra Round and Shaped Breast Implants, the first FDA-approved fifth generation breast implants for sale in the United States, the breakthrough Allox2® breast tissue expander with patented dual-port and integrated drainage technology, and BIOCORNEUM ®, the leading, preferred and recommended scar gel by plastic surgeons
.
Sientra uses its investor relations website to post important information about the company, including information that may be considered material to investors. Financial and other information about Sientra is published regularly and is available on the company’s investor relations website at www.sientra.com.
Data in file
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, based on management’s current beliefs and expectations of future events Trends that affect or may affect the company’s business, strategy, operations, or financial performance, and actual results could differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements speak only as of the date of this press release. The words ” believe ” ” may ” ” could ” ” could ” ” be ” ” aim ” ” estimate ” ” continue ” anticipate ” ” intend ” ” expect ” ” plan ” ” position ” or the negative of these terms, and similar expressions that express the uncertainty of future events or results, are used to identify estimates, projections and other forward-looking statements. Forward-looking statements may include information about the company’s expanding market share, the company’s advancement in plastic surgery, the company’s acceleration in growth, and the company’s goal of becoming a top two implant manufacturer in two years’ time. Such statements are subject to risks and uncertainties, including the size and duration of the COVID-19 pandemic, the company’s ability to recapture delayed procedures due to the COVID-19 pandemic, the positive response from plastic surgeons and their patients to Sientra’s breast products , the positive response from plastic surgeons and patients to Sientra’s marketing, sales and education programs and the ability to implement the company’s commercial, product development and manufacturing initiatives. Please refer to the Risk Factors section of Sientra’s public filings with the Securities and Exchange Commission for additional factors that could cause actual results to differ materially from those discussed in this press release. All statements that are not historical facts are forward-looking statements. The words ” believe ” ” may ” ” could ” ” could ” ” be ” ” aim ” ” estimate ” ” continue ” anticipate ” ” intend ” ” expect ” ” plan ” ” position ” or the negative of these terms, and similar expressions that express the uncertainty of future events or results, are used to identify estimates, projections and other forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements and such estimates, projections and other forward-looking statements speak only as of the date of their publication and the company undertakes no obligation to update any estimates, projections or forward-looking statements unless required by law or check. Actual results could differ from those disclosed in this press release due to the risks and uncertainties inherent in the company’s business.
Investor Relations contact
Leigh Salvo ir@sietra.com
[ad_2]
